Pharmac Widens Access To Medicine For RSV

Pharmac has announced today that it will be funding the preventative treatment, palivizumab, for the next two seasons of respiratory syncytial virus (RSV) for young children with severe diseases who need to be ventilated and pēpi (babies) with a ...